These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 11290585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.
    Adya N, Stacy T, Speck NA, Liu PP.
    Mol Cell Biol; 1998 Dec; 18(12):7432-43. PubMed ID: 9819429
    [Abstract] [Full Text] [Related]

  • 3. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
    Kundu M, Chen A, Anderson S, Kirby M, Xu L, Castilla LH, Bodine D, Liu PP.
    Blood; 2002 Oct 01; 100(7):2449-56. PubMed ID: 12239155
    [Abstract] [Full Text] [Related]

  • 4. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo.
    Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marín-Padilla M, Sharpe AH, Speck NA.
    Cell; 1996 Nov 15; 87(4):697-708. PubMed ID: 8929538
    [Abstract] [Full Text] [Related]

  • 5. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
    Hyde RK, Zhao L, Alemu L, Liu PP.
    Leukemia; 2015 Aug 15; 29(8):1771-8. PubMed ID: 25742748
    [Abstract] [Full Text] [Related]

  • 6. Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.
    Wijmenga C, Gregory PE, Hajra A, Schröck E, Ried T, Eils R, Liu PP, Collins FS.
    Proc Natl Acad Sci U S A; 1996 Feb 20; 93(4):1630-5. PubMed ID: 8643682
    [Abstract] [Full Text] [Related]

  • 7. Function of the inv(16) fusion gene CBFB-MYH11.
    Kundu M, Liu PP.
    Curr Opin Hematol; 2001 Jul 20; 8(4):201-5. PubMed ID: 11561156
    [Abstract] [Full Text] [Related]

  • 8. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
    Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, Satake M, Takada K, Komori T.
    Nat Genet; 2002 Dec 20; 32(4):633-8. PubMed ID: 12434152
    [Abstract] [Full Text] [Related]

  • 9. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.
    Durst KL, Lutterbach B, Kummalue T, Friedman AD, Hiebert SW.
    Mol Cell Biol; 2003 Jan 20; 23(2):607-19. PubMed ID: 12509458
    [Abstract] [Full Text] [Related]

  • 10. Core-binding factor: a central player in hematopoiesis and leukemia.
    Speck NA, Stacy T, Wang Q, North T, Gu TL, Miller J, Binder M, Marín-Padilla M.
    Cancer Res; 1999 Apr 01; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
    Huang G, Shigesada K, Wee HJ, Liu PP, Osato M, Ito Y.
    Blood; 2004 Apr 15; 103(8):3200-7. PubMed ID: 15070703
    [Abstract] [Full Text] [Related]

  • 12. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
    Zhen T, Cao Y, Ren G, Zhao L, Hyde RK, Lopez G, Feng D, Alemu L, Zhao K, Liu PP.
    Blood; 2020 Nov 19; 136(21):2373-2385. PubMed ID: 32929473
    [Abstract] [Full Text] [Related]

  • 13. Cbfbeta interacts with Runx2 and has a critical role in bone development.
    Kundu M, Javed A, Jeon JP, Horner A, Shum L, Eckhaus M, Muenke M, Lian JB, Yang Y, Nuckolls GH, Stein GS, Liu PP.
    Nat Genet; 2002 Dec 19; 32(4):639-44. PubMed ID: 12434156
    [Abstract] [Full Text] [Related]

  • 14. The core binding factor (CBF) alpha interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFbeta-SMMHC are both required to slow cell proliferation.
    Cao W, Adya N, Britos-Bray M, Liu PP, Friedman AD.
    J Biol Chem; 1998 Nov 20; 273(47):31534-40. PubMed ID: 9813068
    [Abstract] [Full Text] [Related]

  • 15. Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability.
    Wunderlich M, Krejci O, Wei J, Mulloy JC.
    Blood; 2006 Sep 01; 108(5):1690-7. PubMed ID: 16670269
    [Abstract] [Full Text] [Related]

  • 16. HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.
    Richter LE, Wang Y, Becker ME, Coburn RA, Williams JT, Amador C, Hyde RK.
    Mol Cancer Res; 2019 Jun 01; 17(6):1241-1252. PubMed ID: 30814129
    [Abstract] [Full Text] [Related]

  • 17. Multimerization via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncoprotein.
    Kummalue T, Lou J, Friedman AD.
    Mol Cell Biol; 2002 Dec 01; 22(23):8278-91. PubMed ID: 12417730
    [Abstract] [Full Text] [Related]

  • 18. Energetic and functional contribution of residues in the core binding factor beta (CBFbeta ) subunit to heterodimerization with CBFalpha.
    Tang YY, Shi J, Zhang L, Davis A, Bravo J, Warren AJ, Speck NA, Bushweller JH.
    J Biol Chem; 2000 Dec 15; 275(50):39579-88. PubMed ID: 10984496
    [Abstract] [Full Text] [Related]

  • 19. CBFbeta-SMMHC slows proliferation of primary murine and human myeloid progenitors.
    D'Costa J, Chaudhuri S, Civin CI, Friedman AD.
    Leukemia; 2005 Jun 15; 19(6):921-9. PubMed ID: 15815715
    [Abstract] [Full Text] [Related]

  • 20. Zebrafish homolog of the leukemia gene CBFB: its expression during embryogenesis and its relationship to scl and gata-1 in hematopoiesis.
    Blake T, Adya N, Kim CH, Oates AC, Zon L, Chitnis A, Weinstein BM, Liu PP.
    Blood; 2000 Dec 15; 96(13):4178-84. PubMed ID: 11110689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.